APA (7th ed.) Citation

C, M., P, S., N, M., R, N., I, d. l. R., I, U., . . . N, E. (2022). ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma. Molecular oncology, 16(11), 2235. https://doi.org/10.1002/1878-0261.13193

Chicago Style (17th ed.) Citation

C, Megino-Luque, et al. "ARID1A-deficient Cells Require HDAC6 for Progression of Endometrial Carcinoma." Molecular Oncology 16, no. 11 (2022): 2235. https://doi.org/10.1002/1878-0261.13193.

MLA (9th ed.) Citation

C, Megino-Luque, et al. "ARID1A-deficient Cells Require HDAC6 for Progression of Endometrial Carcinoma." Molecular Oncology, vol. 16, no. 11, 2022, p. 2235, https://doi.org/10.1002/1878-0261.13193.